日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Understanding the gap between expectations and reality in decentralized clinical trials

了解分散式临床试验中预期与现实之间的差距

期刊:npj Digital Medicine
影响因子:15.1
doi:10.1038/s41746-025-01811-y
Jiang, Yale; Leng, Ye; Wu, Qing; Hou, Yiru; Dong, Xueyuan; Zeng, Caiwen; Wu, Dawei; Fang, Hong; Tang, Yu; Huang, Huiyao; Li, Ning
发表日期：2025
文献求助 收藏

Clinical benefits of immune checkpoint inhibitors for malignant peripheral nerve sheath tumors with NF2 mutation: a case report

免疫检查点抑制剂治疗伴有NF2突变的恶性周围神经鞘瘤的临床疗效：病例报告

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1596348
Jiang, Yale; Zhao, Guo; Tang, Qiyu; Xing, Shujun; Wang, Shuhang; Li, Ning
免疫/内分泌
发表日期：2025
文献求助 收藏

Integrative Analysis of Immune- and Metabolism-Related Genes Identifies Robust Prognostic Signature and PYCR1 as a Carcinogenic Regulator in Clear Cell Renal Cell Carcinoma.

免疫和代谢相关基因的综合分析确定了可靠的预后特征，并将 PYCR1 鉴定为透明细胞肾细胞癌的致癌调节因子

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms26104953
Zhao Guo, Ding Jiatong, Ma Jiaxiu, Jiang Yale, Wang Yuning, Wang Shuhang, Li Ning
代谢
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Sporadic Human Infections With Rickettsia japonica in Yichang, China, 2021-2023

2021-2023年中国宜昌市散发性日本立克次体人类感染病例

期刊:Transboundary and Emerging Diseases
影响因子:3
doi:10.1155/tbed/4832524
Ren, Yuting; Jiang, Yale; Xiang, Zhoufu; Cheng, Qi; Chen, Kehan; Ma, Jianchun; Dai, Jianwei; Zhang, Weihao; Hou, Wei; Liu, Qiang; Chen, Liangjun
Human
炎症/感染
发表日期：2025
文献求助 收藏

Mobilizing China and the Global Community to Confront the Treatment Desert for Pediatric Solid Tumors

动员中国和国际社会共同应对儿童实体瘤治疗荒漠问题

期刊:Cancer Discovery
影响因子:33.3
doi:10.1158/2159-8290.CD-23-0451
Wang, Shuhang; Jiang, Yale; Zheng, Rongshou; Yu, Yue; Wei, Wenqiang; Li, Ning
发表日期：2024
文献求助 收藏

Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood-brain barrier

用于治疗脑肿瘤的纳米颗粒药物递送系统：突破血脑屏障

期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2024.03.023
Tang, Qiyu; Zhao, Guo; Fang, Hong; Jiang, Yale; Ma, Peiwen; Zhou, Jiawei; Liu, Dongyan; Xing, Shujun; Li, Gaoquan; Liu, Nian; Chen, Huiyu; Wang, Shuhang; Li, Ning
血脑屏障
肿瘤
肿瘤免疫
神经科学
发表日期：2024
文献求助 收藏

The global landscape of clinical trials and drug discovery for brain metastasis

脑转移瘤临床试验和药物研发的全球概况

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05310-8
Ding, Jiatong; Jiang, Yale; Zhou, Jiawei; Tang, Qiyu; Xing, Shujun; Wang, Shuhang; Li, Ning
神经科学
发表日期：2024
文献求助 收藏

Comprehensive characterization of cell disulfidptosis in human cancers: An integrated pan-cancer analysis

人类癌症中细胞二硫键凋亡的全面表征：一项综合泛癌分析

期刊:Genes and Diseases
影响因子:
doi:10.1016/j.gendis.2023.101095
Zhao, Guo; Jiang, Yale; Wang, Yuning; Wang, Shuhang; Li, Ning
凋亡
肿瘤
表观遗传
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

Targeting rare tumors: new focus for clinical research in China

针对罕见肿瘤：中国临床研究的新焦点

期刊:EMBO Molecular Medicine
影响因子:8.3
doi:10.15252/emmm.202216415
Wang, Shuhang; Jiang, Yale; Miao, Huilei; Fang, Yuan; Jiang, Ning; Yu, Yue; Ma, Peiwen; Tang, Qiyu; Cui, Dandan; Fang, Hong; Huang, Huiyao; Fan, Qi; Sun, Chao; Yu, Anqi; Miao, Shuangman; Du, Jingting; Zhu, Jingxiao; Wang, Yuning; Li, Ning
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Seven-year exclusivity and beyond for drugs of rare diseases in China

中国罕见病药物享有七年及以上的独家销售权。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1223056
Jiang, Yale; Huang, Huiyao; Zhao, Guo; Ma, Peiwen; Zhang, Liang; Wang, Shuhang; Li, Ning
发表日期：2023
文献求助 收藏